世界の硬化療法市場:成長動向・競争分析2020-2026

【英語タイトル】Global Sclerotherapy Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

QYResearchが出版した調査資料(QYR20AP02122)・商品コード:QYR20AP02122
・発行会社(調査会社):QYResearch
・発行日:2020年3月20日(※2024年版があります。お問い合わせください)
・ページ数:117
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当リサーチレポートでは、硬化療法の世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、硬化療法のグローバル市場動向、メーカー別競争状況、種類別市場規模(洗剤、浸透圧剤、化学刺激剤)、用途別市場規模(静脈疾患、消化管出血、気管支胸膜f、嚢胞性疾患)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・硬化療法の種類別市場2015-2026:洗剤、浸透圧剤、化学刺激剤
・硬化療法の用途別市場2015-2026:静脈疾患、消化管出血、気管支胸膜f、嚢胞性疾患
・硬化療法の北米市場分析
・硬化療法のアジア市場分析
・硬化療法の中南米市場分析
・硬化療法の中東・アフリカ市場分析
・関連企業情報:BTG、Kreussler、LGM Pharma、Troikaa、Changan Tianyu group、Bioniche Pharma Group Ltd、Omega Pharmaceuticals、Angiodynamics、ENDO-FLEX、MTW ENDOSKOPIE、Cook Medical
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

Sclerotherapy is a procedure used to treat blood vessels or blood vessel malformations (vascular malformations) and also those of the lymphatic system. A medicine is injected into the vessels, which makes them shrink. It is used for children and young adults with vascular or lymphatic malformations. In adults, sclerotherapy is often used to treat spider veins, smaller varicose veins, and hemorrhoids.Now more respected hospital minimally invasive surgical procedure, Sclerotherapy Treatment is relatively old. And there is a lot of shortcomings hardener. For example, it will be very painful in the course of treatment. But also produce pigmentation, or inflammation, swelling and other consequences, so I do not recommend using this method for the treatment of vascular malformations
Average industry gross margin is about 63.95%. However, due to the emergence of new treatments is not recommended investment.
In 2019, the global Sclerotherapy market size was US$ xx million and is forecast to US$ xx million in 2026, growing at a CAGR of xx% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Sclerotherapy.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Sclerotherapy market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Sclerotherapy market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Sclerotherapy market. Readers of the report can become informed about current and future trends of the global Sclerotherapy market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Sclerotherapy markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Sclerotherapy market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Sclerotherapy market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Sclerotherapy market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Sclerotherapy market is segmented into
Detergents
Osmotic agents
Chemical irritants

Market Segment by Application, the Sclerotherapy market is segmented into
Venous disease
Gastrointestinal bleeding
Bronchopleural fistula
Cystic disease

This report includes the following manufacturers; we can also add the other companies as you want.
BTG
Kreussler
LGM Pharma
Troikaa
Changan Tianyu group
Bioniche Pharma Group Ltd
Omega Pharmaceuticals
Angiodynamics
ENDO-FLEX
MTW ENDOSKOPIE
Cook Medical

The study objectives are:
To analyze and research the global Sclerotherapy status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Sclerotherapy manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Sclerotherapy are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Sclerotherapy Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Sclerotherapy Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Detergents
1.3.3 Osmotic agents
1.3.4 Chemical irritants
1.4 Market Segment by Application
1.4.1 Global Sclerotherapy Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Venous disease
1.4.3 Gastrointestinal bleeding
1.4.4 Bronchopleural fistula
1.4.5 Cystic disease
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Sclerotherapy Revenue (2015-2026)
2.1.1 Global Sclerotherapy Revenue (2015-2026)
2.1.2 Global Sclerotherapy Sales (2015-2026)
2.2 Sclerotherapy Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Sclerotherapy Sales by Regions (2015-2020)
2.2.2 Global Sclerotherapy Revenue by Regions (2015-2020)
2.3 Global Top Sclerotherapy Regions (Countries) Ranking by Market Size
2.4 Sclerotherapy Industry Trends
2.4.1 Sclerotherapy Market Top Trends
2.4.2 Market Drivers
2.4.3 Sclerotherapy Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Sclerotherapy Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Sclerotherapy Manufacturers by Sales (2015-2020)
3.1.1 Global Sclerotherapy Sales by Manufacturers (2015-2020)
3.1.2 Global Sclerotherapy Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Sclerotherapy Sales in 2019
3.2 Global Top Manufacturers Sclerotherapy by Revenue
3.2.1 Global Sclerotherapy Revenue by Manufacturers (2015-2020)
3.2.2 Global Sclerotherapy Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Sclerotherapy Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sclerotherapy as of 2019)
3.4 Global Sclerotherapy Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Sclerotherapy Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Sclerotherapy Market
3.7 Key Manufacturers Sclerotherapy Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Sclerotherapy Historic Market Review by Type (2015-2020)
4.1.2 Global Sclerotherapy Sales Market Share by Type (2015-2020)
4.1.3 Global Sclerotherapy Revenue Market Share by Type (2015-2020)
4.1.4 Sclerotherapy Price by Type (2015-2020)
4.1 Global Sclerotherapy Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Sclerotherapy Sales Forecast by Type (2021-2026)
4.2.3 Global Sclerotherapy Revenue Forecast by Type (2021-2026)
4.2.4 Sclerotherapy Price Forecast by Type (2021-2026)

5 Global Sclerotherapy Market Size by Application
5.1 Global Sclerotherapy Historic Market Review by Application (2015-2020)
5.1.2 Global Sclerotherapy Sales Market Share by Application (2015-2020)
5.1.3 Global Sclerotherapy Revenue Market Share by Application (2015-2020)
5.1.4 Sclerotherapy Price by Application (2015-2020)
5.2 Global Sclerotherapy Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Sclerotherapy Sales Forecast by Application (2021-2026)
5.2.3 Global Sclerotherapy Revenue Forecast by Application (2021-2026)
5.2.4 Sclerotherapy Price Forecast by Application (2021-2026)

6 North America
6.1 North America Sclerotherapy Breakdown Data by Company
6.2 North America Sclerotherapy Breakdown Data by Type
6.3 North America Sclerotherapy Breakdown Data by Application
6.4 North America Sclerotherapy Breakdown Data by Countries
6.4.1 North America Sclerotherapy Sales by Countries
6.4.2 North America Sclerotherapy Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Sclerotherapy Breakdown Data by Company
7.2 Europe Sclerotherapy Breakdown Data by Type
7.3 Europe Sclerotherapy Breakdown Data by Application
7.4 Europe Sclerotherapy Breakdown Data by Countries
7.4.1 Europe Sclerotherapy Sales by Countries
7.4.2 Europe Sclerotherapy Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Sclerotherapy Breakdown Data by Company
8.2 Asia Pacific Sclerotherapy Breakdown Data by Type
8.3 Asia Pacific Sclerotherapy Breakdown Data by Application
8.4 Asia Pacific Sclerotherapy Breakdown Data by Regions
8.4.1 Asia Pacific Sclerotherapy Sales by Regions
8.4.2 Asia Pacific Sclerotherapy Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Sclerotherapy Breakdown Data by Company
9.2 Latin America Sclerotherapy Breakdown Data by Type
9.3 Latin America Sclerotherapy Breakdown Data by Application
9.4 Latin America Sclerotherapy Breakdown Data by Countries
9.4.1 Latin America Sclerotherapy Sales by Countries
9.4.2 Latin America Sclerotherapy Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Sclerotherapy Breakdown Data by Type
10.2 Middle East and Africa Sclerotherapy Breakdown Data by Application
10.3 Middle East and Africa Sclerotherapy Breakdown Data by Countries
10.3.1 Middle East and Africa Sclerotherapy Sales by Countries
10.3.2 Middle East and Africa Sclerotherapy Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 BTG
11.1.1 BTG Corporation Information
11.1.2 BTG Business Overview and Total Revenue (2019 VS 2018)
11.1.3 BTG Sclerotherapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 BTG Sclerotherapy Products and Services
11.1.5 BTG SWOT Analysis
11.1.6 BTG Recent Developments
11.2 Kreussler
11.2.1 Kreussler Corporation Information
11.2.2 Kreussler Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Kreussler Sclerotherapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Kreussler Sclerotherapy Products and Services
11.2.5 Kreussler SWOT Analysis
11.2.6 Kreussler Recent Developments
11.3 LGM Pharma
11.3.1 LGM Pharma Corporation Information
11.3.2 LGM Pharma Business Overview and Total Revenue (2019 VS 2018)
11.3.3 LGM Pharma Sclerotherapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 LGM Pharma Sclerotherapy Products and Services
11.3.5 LGM Pharma SWOT Analysis
11.3.6 LGM Pharma Recent Developments
11.4 Troikaa
11.4.1 Troikaa Corporation Information
11.4.2 Troikaa Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Troikaa Sclerotherapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Troikaa Sclerotherapy Products and Services
11.4.5 Troikaa SWOT Analysis
11.4.6 Troikaa Recent Developments
11.5 Changan Tianyu group
11.5.1 Changan Tianyu group Corporation Information
11.5.2 Changan Tianyu group Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Changan Tianyu group Sclerotherapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Changan Tianyu group Sclerotherapy Products and Services
11.5.5 Changan Tianyu group SWOT Analysis
11.5.6 Changan Tianyu group Recent Developments
11.6 Bioniche Pharma Group Ltd
11.6.1 Bioniche Pharma Group Ltd Corporation Information
11.6.2 Bioniche Pharma Group Ltd Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Bioniche Pharma Group Ltd Sclerotherapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Bioniche Pharma Group Ltd Sclerotherapy Products and Services
11.6.5 Bioniche Pharma Group Ltd SWOT Analysis
11.6.6 Bioniche Pharma Group Ltd Recent Developments
11.7 Omega Pharmaceuticals
11.7.1 Omega Pharmaceuticals Corporation Information
11.7.2 Omega Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Omega Pharmaceuticals Sclerotherapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Omega Pharmaceuticals Sclerotherapy Products and Services
11.7.5 Omega Pharmaceuticals SWOT Analysis
11.7.6 Omega Pharmaceuticals Recent Developments
11.8 Angiodynamics
11.8.1 Angiodynamics Corporation Information
11.8.2 Angiodynamics Business Overview and Total Revenue (2019 VS 2018)
11.8.3 Angiodynamics Sclerotherapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 Angiodynamics Sclerotherapy Products and Services
11.8.5 Angiodynamics SWOT Analysis
11.8.6 Angiodynamics Recent Developments
11.9 ENDO-FLEX
11.9.1 ENDO-FLEX Corporation Information
11.9.2 ENDO-FLEX Business Overview and Total Revenue (2019 VS 2018)
11.9.3 ENDO-FLEX Sclerotherapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 ENDO-FLEX Sclerotherapy Products and Services
11.9.5 ENDO-FLEX SWOT Analysis
11.9.6 ENDO-FLEX Recent Developments
11.10 MTW ENDOSKOPIE
11.10.1 MTW ENDOSKOPIE Corporation Information
11.10.2 MTW ENDOSKOPIE Business Overview and Total Revenue (2019 VS 2018)
11.10.3 MTW ENDOSKOPIE Sclerotherapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.10.4 MTW ENDOSKOPIE Sclerotherapy Products and Services
11.10.5 MTW ENDOSKOPIE SWOT Analysis
11.10.6 MTW ENDOSKOPIE Recent Developments
11.11 Cook Medical
11.11.1 Cook Medical Corporation Information
11.11.2 Cook Medical Business Overview and Total Revenue (2019 VS 2018)
11.11.3 Cook Medical Sclerotherapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.11.4 Cook Medical Sclerotherapy Products and Services
11.11.5 Cook Medical SWOT Analysis
11.11.6 Cook Medical Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Sclerotherapy Sales Channels
12.2.2 Sclerotherapy Distributors
12.3 Sclerotherapy Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Sclerotherapy Sales Forecast (2021-2026)
13.1.1 Global Sclerotherapy Sales Forecast by Regions (2021-2026)
13.1.2 Global Sclerotherapy Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Sclerotherapy Sales Forecast (2021-2026)
13.2.2 North America Sclerotherapy Revenue Forecast (2021-2026)
13.2.3 North America Sclerotherapy Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Sclerotherapy Sales Forecast (2021-2026)
13.3.2 Europe Sclerotherapy Revenue Forecast (2021-2026)
13.3.3 Europe Sclerotherapy Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Sclerotherapy Sales Forecast (2021-2026)
13.4.2 Asia Pacific Sclerotherapy Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Sclerotherapy Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Sclerotherapy Sales Forecast (2021-2026)
13.5.2 Latin America Sclerotherapy Revenue Forecast (2021-2026)
13.5.3 Latin America Sclerotherapy Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Sclerotherapy Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Sclerotherapy Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Sclerotherapy Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Sclerotherapy Key Market Segments
Table 2. Ranking of Global Top Sclerotherapy Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Sclerotherapy Market Size Growth Rate by Type 2021-2026 (K Pcs) & (Million US$)
Table 4. Major Manufacturers of Detergents
Table 5. Major Manufacturers of Osmotic agents
Table 6. Major Manufacturers of Chemical irritants
Table 7. Global Sclerotherapy Market Share by Application 2019-2025 (K Pcs)
Table 8. Global Sclerotherapy Market Size by Regions 2015-2020 (K Pcs) & (Million US$)
Table 9. Global Sclerotherapy Sales by Regions 2015-2020 (K Pcs)
Table 10. Global Sclerotherapy Sales Market Share by Regions 2015-2020
Table 11. Global Sclerotherapy Revenue by Regions 2015-2020 (Million US$)
Table 12. Global Sclerotherapy Revenue Market Share by Regions 2015-2020
Table 13. Top Sclerotherapy Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 14. Market Top Trends
Table 15. Sclerotherapy Key Drivers: Impact Analysis (2021-2026)
Table 16. Sclerotherapy Key Challenges
Table 17. Main Points Interviewed from Key Sclerotherapy Players: Views for Future
Table 18. Global Sclerotherapy Sales by Manufacturers (2015-2020) (K Pcs)
Table 19. Global Sclerotherapy Sales Share by Manufacturers (2015-2020)
Table 20. Sclerotherapy Revenue by Manufacturers (2015-2020) (Million US$)
Table 21. Sclerotherapy Revenue Share by Manufacturers (2015-2020)
Table 22. Global Sclerotherapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sclerotherapy as of 2019)
Table 24. Key Manufacturers Sclerotherapy Average Selling Price (ASP) (2015-2020) (USD/Pcs)
Table 25. Key Manufacturers Sclerotherapy Plants/Factories Distribution
Table 26. Key Manufacturers Sclerotherapy Area Served
Table 27. Date of Key Manufacturers Enter into Sclerotherapy Market
Table 28. Key Manufacturers Sclerotherapy Product Type
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Detergents Sales and Revenue (2015-2020) (K Pcs) & (Million US$)
Table 31. Global Osmotic agents Sales and Revenue (2015-2020) (K Pcs) & (Million US$)
Table 32. Global Chemical irritants Sales ana Revenue (2015-2020) (K Pcs) & (Million US$)
Table 33. Global Sclerotherapy Sales (K Pcs) by Type (2015-2020)
Table 34. Global Sclerotherapy Sales Share by Type (2015-2020)
Table 35. Global Sclerotherapy Revenue (US$ Million) Market Share by Type (2015-2020)
Table 36. Global Sclerotherapy Price (K Pcs) by Type (2015-2020)
Table 37. Global Sclerotherapy Sales (K Pcs) by Type (2021-2026)
Table 38. Global Sclerotherapy Sales Share by Type (2021-2026)
Table 39. Global Sclerotherapy Revenue (US$ Million) Market Share by Type (2021-2026)
Table 40. Global Sclerotherapy Revenue Share by Type (2021-2026)
Table 41. Global Sclerotherapy Price (K Pcs) by Type (2021-2026)
Table 42. Global Sclerotherapy Sales (K Pcs) by Application (2015-2020)
Table 43. Global Sclerotherapy Sales Share by Application (2015-2020)
Table 44. Global Sclerotherapy Revenue (US$ Million) Market Share by Application (2015-2020)
Table 45. Global Sclerotherapy Price by Application 2015-2020 (USD/Pcs)
Table 46. Global Sclerotherapy Sales by Application (2015-2020) (K Pcs)
Table 47. Global Sclerotherapy Sales Share by Application (2015-2020)
Table 48. Global Sclerotherapy Revenue (US$ Million) Market Share by Application (2021-2026)
Table 49. Global Sclerotherapy Revenue Share by Application (2021-2026)
Table 50. Global Sclerotherapy Price (K Pcs) by Application (2021-2026)
Table 51. North America Sclerotherapy Sales by Company (2015-2020) (K Pcs)
Table 52. North America Sclerotherapy Sales Market Share by Company (2015-2020)
Table 53. North America Sclerotherapy Sales by Type (2015-2020) (K Pcs)
Table 54. North America Sclerotherapy Sales Market Share by Type (2015-2020)
Table 55. North America Sclerotherapy Sales by Application (2015-2020) (K Pcs)
Table 56. North America Sclerotherapy Sales Market Share by Application (2015-2020)
Table 57. North America Sclerotherapy Sales by Countries (2015-2020) (K Pcs)
Table 58. North America Sclerotherapy Sales Market Share by Countries (2015-2020)
Table 59. North America Sclerotherapy Revenue by Countries (2015-2020) (Million US$)
Table 60. North America Sclerotherapy Revenue Market Share by Countries (2015-2020)
Table 61. Europe Sclerotherapy Sales by Company (2015-2020) (K Pcs)
Table 62. Europe Sclerotherapy Sales Market Share by Company (2015-2020)
Table 63. Europe Sclerotherapy Sales by Type (2015-2020) (K Pcs)
Table 64. Europe Sclerotherapy Sales Market Share by Type (2015-2020)
Table 65. Europe Sclerotherapy Sales by Application (2015-2020) (K Pcs)
Table 66. Europe Sclerotherapy Sales Market Share by Application (2015-2020)
Table 67. Europe Sclerotherapy Sales by Countries (2015-2020) (K Pcs)
Table 68. Europe Sclerotherapy Sales Market Share by Countries (2015-2020)
Table 69. Europe Sclerotherapy Revenue by Countries (2015-2020) (Million US$)
Table 70. Europe Sclerotherapy Revenue Market Share by Countries (2015-2020)
Table 71. Asia Pacific Sclerotherapy Sales by Regions (2015-2020) (K Pcs)
Table 72. Asia Pacific Sclerotherapy Sales Market Share by Regions (2015-2020)
Table 73. Asia Pacific Sclerotherapy Sales by Type (2015-2020) (K Pcs)
Table 74. Asia Pacific Sclerotherapy Sales Market Share by Type (2015-2020)
Table 75. Asia Pacific Sclerotherapy Sales by Application (2015-2020) (K Pcs)
Table 76. Asia Pacific Sclerotherapy Sales Market Share by Application (2015-2020)
Table 77. Asia Pacific Sclerotherapy Sales by Countries (2015-2020) (K Pcs)
Table 78. Asia Pacific Sclerotherapy Sales Market Share by Regions (2015-2020)
Table 79. Asia Pacific Sclerotherapy Revenue by Regions (2015-2020) (Million US$)
Table 80. Asia Pacific Sclerotherapy Revenue Market Share by Regions (2015-2020)
Table 81. Latin America Sclerotherapy Sales by Company (2015-2020) (K Pcs)
Table 82. Latin America Sclerotherapy Sales Market Share by Company (2015-2020)
Table 83. Latin America Sclerotherapy Sales by Type (2015-2020) (K Pcs)
Table 84. Latin America Sclerotherapy Sales Market Share by Type (2015-2020)
Table 85. Latin America Sclerotherapy Sales by Application (2015-2020) (K Pcs)
Table 86. Latin America Sclerotherapy Sales Market Share by Application (2015-2020)
Table 87. Latin America Sclerotherapy Sales by Countries (2015-2020) (K Pcs)
Table 88. Latin America Sclerotherapy Sales Market Share by Countries (2015-2020)
Table 89. Latin America Sclerotherapy Revenue by Countries (2015-2020) (Million US$)
Table 90. Latin America Sclerotherapy Revenue Market Share by Countries (2015-2020)
Table 91. Middle East and Africa Sclerotherapy Sales by Type (2015-2020) (K Pcs)
Table 92. Middle East and Africa Sclerotherapy Sales Market Share by Type (2015-2020)
Table 93. Middle East and Africa Sclerotherapy Sales by Application (2015-2020) (K Pcs)
Table 94. Middle East and Africa Sclerotherapy Sales Market Share by Application (2015-2020)
Table 95. Middle East and Africa Sclerotherapy Sales by Countries (2015-2020) (K Pcs)
Table 96. Middle East and Africa Sclerotherapy Sales Market Share by Countries (2015-2020)
Table 97. Middle East and Africa Sclerotherapy Revenue by Countries (2015-2020) (Million US$)
Table 98. Middle East and Africa Sclerotherapy Revenue Market Share by Countries (2015-2020)
Table 99. BTG Company Details
Table 100. BTG Description and Business Overview
Table 101. BTG Sclerotherapy Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 102. BTG Sclerotherapy Sales Growth Rate (2015-2020)
Table 103. BTG Sclerotherapy Sales Market Share in Global Market
Table 104. BTG Recent Development
Table 105. Kreussler Company Details
Table 106. Kreussler Description and Business Overview
Table 107. Kreussler Sclerotherapy Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Kreussler Sclerotherapy Sales Growth Rate (2015-2020)
Table 109. Kreussler Sclerotherapy Sales Market Share in Global Market
Table 110. Kreussler Recent Development
Table 111. LGM Pharma Company Details
Table 112. LGM Pharma Description and Business Overview
Table 113. LGM Pharma Sclerotherapy Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 114. LGM Pharma Sclerotherapy Sales Growth Rate (2015-2020)
Table 115. LGM Pharma Sclerotherapy Sales Market Share in Global Market
Table 116. LGM Pharma Recent Development
Table 117. Troikaa Company Details
Table 118. Troikaa Description and Business Overview
Table 119. Troikaa Sclerotherapy Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 120. Troikaa Sclerotherapy Sales Growth Rate (2015-2020)
Table 121. Troikaa Sclerotherapy Sales Market Share in Global Market
Table 122. Troikaa Recent Development
Table 123. Changan Tianyu group Company Details
Table 124. Changan Tianyu group Description and Business Overview
Table 125. Changan Tianyu group Sclerotherapy Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 126. Changan Tianyu group Sclerotherapy Sales Growth Rate (2015-2020)
Table 127. Changan Tianyu group Sclerotherapy Sales Market Share in Global Market
Table 128. Changan Tianyu group Recent Development
Table 129. Bioniche Pharma Group Ltd Company Details
Table 130. Bioniche Pharma Group Ltd Description and Business Overview
Table 131. Bioniche Pharma Group Ltd Sclerotherapy Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 132. Bioniche Pharma Group Ltd Sclerotherapy Sales Growth Rate (2015-2020)
Table 133. Bioniche Pharma Group Ltd Sclerotherapy Sales Market Share in Global Market
Table 134. Bioniche Pharma Group Ltd Recent Development
Table 135. Omega Pharmaceuticals Company Details
Table 136. Omega Pharmaceuticals Description and Business Overview
Table 137. Omega Pharmaceuticals Sclerotherapy Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 138. Omega Pharmaceuticals Sclerotherapy Sales Growth Rate (2015-2020)
Table 139. Omega Pharmaceuticals Sclerotherapy Sales Market Share in Global Market
Table 140. Omega Pharmaceuticals Recent Development
Table 141. Angiodynamics Company Details
Table 142. Angiodynamics Description and Business Overview
Table 143. Angiodynamics Sclerotherapy Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 144. Angiodynamics Sclerotherapy Sales Growth Rate (2015-2020)
Table 145. Angiodynamics Sclerotherapy Sales Market Share in Global Market
Table 146. Angiodynamics Recent Development
Table 147. ENDO-FLEX Company Details
Table 148. ENDO-FLEX Description and Business Overview
Table 149. ENDO-FLEX Sclerotherapy Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 150. ENDO-FLEX Sclerotherapy Sales Growth Rate (2015-2020)
Table 151. ENDO-FLEX Sclerotherapy Sales Market Share in Global Market
Table 152. ENDO-FLEX Recent Development
Table 153. MTW ENDOSKOPIE Company Details
Table 154. MTW ENDOSKOPIE Description and Business Overview
Table 155. MTW ENDOSKOPIE Sclerotherapy Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 156. MTW ENDOSKOPIE Sclerotherapy Sales Growth Rate (2015-2020)
Table 157. MTW ENDOSKOPIE Sclerotherapy Sales Market Share in Global Market
Table 158. MTW ENDOSKOPIE Recent Development
Table 159. Cook Medical Company Details
Table 160. Cook Medical Description and Business Overview
Table 161. Cook Medical Sclerotherapy Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 162. Cook Medical Sclerotherapy Sales Growth Rate (2015-2020)
Table 163. Cook Medical Sclerotherapy Sales Market Share in Global Market
Table 164. Cook Medical Recent Development
Table 165. Sclerotherapy Distributors List
Table 166. Sclerotherapy Customers List
Table 167. Global Sclerotherapy Sales Forecast 2021-2026 (K Pcs) & (Million US$)
Table 168. Global Sclerotherapy Sales Forecast by Type 2021-2026 (K Pcs)
Table 169. Global Sclerotherapy Sales Forecast by Application 2021-2026 (K Pcs)
Table 170. Global Sclerotherapy Sales Forecast by Regions 2021-2026 (K Pcs)
Table 171. Global Sclerotherapy Revenue Forecast by Regions 2021-2026 (Million US$)
Table 172. North America Sclerotherapy Sales Forecast by Countries 2021-2026 (K Pcs)
Table 173. North America Sclerotherapy Revenue Forecast by Countries 2021-2026
Table 174. Europe Sclerotherapy Sales Forecast by Countries 2021-2026 (K Pcs)
Table 175. Europe Sclerotherapy Revenue Market Share Forecast by Countries 2021-2026
Table 176. Asia Pacific Sclerotherapy Sales Forecast by Regions 2021-2026 (K Pcs)
Table 177. Asia Pacific Sclerotherapy Revenue Forecast by Regions 2021-2026 (Million US$)
Table 178. Latin America Sclerotherapy Sales Forecast by Countries 2021-2026 (K Pcs)
Table 179. Latin America Sclerotherapy Revenue Forecast by Countries 2021-2026 (Million US$)
Table 180. Middle East and Africa Sclerotherapy Sales Forecast by Regions 2021-2026 (K Pcs)
Table 181. Middle East and Africa Sclerotherapy Revenue Forecast by Regions 2021-2026 (Million US$)
Table 182. Research Programs/Design for This Report
Table 183. Key Data Information from Secondary Sources
Table 184. Key Data Information from Primary Sources
List of Figures
Figure 1. Sclerotherapy Product Picture
Figure 2. Global Sclerotherapy Sales Market Shar by Type 2015-2026
Figure 3. Detergents Figures
Figure 4. Osmotic agents Figures
Figure 5. Chemical irritants Figures
Figure 6. Global Sclerotherapy Sales Market Share by Application in 2019 & 2026
Figure 7. Venous disease Use Case
Figure 8. Gastrointestinal bleeding Use Case
Figure 9. Bronchopleural fistula Use Case
Figure 10. Cystic disease Use Case
Figure 11. Sclerotherapy Report Years Considered
Figure 12. Global Sclerotherapy Market Size 2015-2026 (Million US$)
Figure 13. Global Sclerotherapy Sales 2015-2020 (K Pcs)
Figure 14. Global Sclerotherapy Market Size Market Share by Regions 2015-2020
Figure 15. Global Sclerotherapy Sales Market Share by Regions in 2019
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Sclerotherapy Sales Share by Manufacturers in 2019
Figure 18. The 5 and 10 Largest Manufacturers in the World: Market Share by Sclerotherapy Sales in 2019
Figure 19. Sclerotherapy Value Share by Manufacturers in 2019
Figure 20. Sclerotherapy Revenue Share by Manufacturers In 2019
Figure 21. Sclerotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Sclerotherapy Revenue Share by Type (2015-2020)
Figure 23. Global Sclerotherapy Revenue Growth Rate by Type in 2015 & 2019
Figure 24. Global Sclerotherapy Market Share by Price Range (2015-2020)
Figure 25. Global Sclerotherapy Revenue Share by Application (2015-2020)
Figure 26. Global Sclerotherapy Revenue Growth Rate by Application in 2015 & 2019
Figure 27. North America Sclerotherapy Revenue Growth Rate 2015-2020 (Million US$)
Figure 28. U.S. Sclerotherapy Sales Growth Rate (2015-2020) (K Pcs)
Figure 29. Canada Sclerotherapy Sales Growth Rate (2015-2020) (K Pcs)
Figure 30. Europe Sclerotherapy Revenue Growth Rate 2015-2020 (Million US$)
Figure 31. Germany Sclerotherapy Sales Growth Rate (2015-2020) (K Pcs)
Figure 32. France Sclerotherapy Sales Growth Rate (2015-2020) (K Pcs)
Figure 33. U.K. Sclerotherapy Sales Growth Rate (2015-2020) (K Pcs)
Figure 34. Italy Sclerotherapy Sales Growth Rate (2015-2020) (K Pcs)
Figure 35. Russia Sclerotherapy Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. Asia Pacific Sclerotherapy Revenue Growth Rate 2015-2020 (Million US$)
Figure 37. China Sclerotherapy Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. Japan Sclerotherapy Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. South Korea Sclerotherapy Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. India Sclerotherapy Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Australia Sclerotherapy Sales Growth Rate (2015-2020) (K Pcs)
Figure 42. Taiwan Sclerotherapy Sales Growth Rate (2015-2020) (K Pcs)
Figure 43. Indonesia Sclerotherapy Sales Growth Rate (2015-2020) (K Pcs)
Figure 44. Thailand Sclerotherapy Sales Growth Rate (2015-2020) (K Pcs)
Figure 45. Malaysia Sclerotherapy Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. Philippines Sclerotherapy Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Vietnam Sclerotherapy Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Latin America Sclerotherapy Revenue Growth Rate 2015-2020 (Million US$)
Figure 49. Mexico Sclerotherapy Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. Brazil Sclerotherapy Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. Argentina Sclerotherapy Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Middle East and Africa Sclerotherapy Revenue Growth Rate 2015-2020 (Million US$)
Figure 53. Turkey Sclerotherapy Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Saudi Arabia Sclerotherapy Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. U.A.E Sclerotherapy Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. BTG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Kreussler Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. LGM Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Troikaa Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Changan Tianyu group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Bioniche Pharma Group Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Omega Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Angiodynamics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. ENDO-FLEX Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. MTW ENDOSKOPIE Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Cook Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. Sclerotherapy Value Chain
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Figure 70. North America Sclerotherapy Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 71. North America Sclerotherapy Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 72. Europe Sclerotherapy Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 73. Europe Sclerotherapy Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 74. Asia Pacific Sclerotherapy Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 75. Asia Pacific Sclerotherapy Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 76. Latin America Sclerotherapy Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 77. Latin America Sclerotherapy Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 78. Middle East and Africa Sclerotherapy Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 79. Middle East and Africa Sclerotherapy Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed


【掲載企業】

BTG、Kreussler、LGM Pharma、Troikaa、Changan Tianyu group、Bioniche Pharma Group Ltd、Omega Pharmaceuticals、Angiodynamics、ENDO-FLEX、MTW ENDOSKOPIE、Cook Medical

★調査レポート[世界の硬化療法市場:成長動向・競争分析2020-2026] (コード:QYR20AP02122)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の硬化療法市場:成長動向・競争分析2020-2026]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆